Considering the function of UGT in steroid hormones metabolism, it has been suggested that variations in the UGT genes, especially the ones that can decrease enzyme amount or activity and further increase individual sex hormone exposure, are involved in breast cancer onset16–19. This evidence concerns the gene SLC35A2 and breast cancer.